Vipergen Publishes First Technology for Screening DNA-Encoded Small-Molecule Libraries (DELs) Inside Living Cells
Vipergen’s Cellular Binder Trap Enrichment® (cBTE) technology provides a robust system to accelerate and improve drug discovery
March 1, 2021
COPENHAGEN, DENMARK February 17, 2021 Vipergen ApS announced today a published study describing a powerful new drug discovery approach that enables, for the first time, screening DNA-encoded small-molecule libraries (DELs) inside living cells. The study, published in the peer-reviewed
Journal of the American Chemical Society, highlights the potential of Vipergen’s Cellular Binder Trap Enrichment® (cBTE) technology to significantly expand the ability to discover novel small molecules, including against difficult-to-drug targets, and reduce attrition rates in drug discovery. Vipergen is offering its cBTE DNA-encoded library drug discovery platform as a service to biotechnology and pharmaceutical company partners to ac